Medications That Cause Direct Tubular Injury
Several classes of medications can cause direct tubular injury, with aminoglycosides, platinum-based chemotherapy agents, and certain other nephrotoxic drugs being the most common culprits. 1
Aminoglycoside Antibiotics
Aminoglycosides are among the most well-documented causes of direct tubular injury:
- Gentamicin: Causes acute tubular necrosis through direct toxicity to proximal tubular cells 2
- Tobramycin: Primarily manifests as acute tubular necrosis with signs including rising BUN and creatinine, decreased urinary output, and urinary losses of sodium, potassium, bicarbonate, magnesium, phosphate, and calcium 3
The nephrotoxicity risk with aminoglycosides increases with:
- Drug accumulation (trough levels above 2 mcg/mL)
- Excessive peak concentrations (above 12 mcg/mL)
- Total cumulative dose
- Advanced age
- Volume depletion
- Concurrent use of other nephrotoxic drugs
- Diabetes 3
Chemotherapeutic Agents
Several anticancer drugs cause direct tubular injury:
- Cisplatin: Causes cross-linking and interference with DNA replication, leading to acute tubular injury and necrosis, proximal tubulopathy, Fanconi syndrome, and electrolyte wasting 1
- Ifosfamide: Nitrogen mustard alkylating agent that causes acute tubular injury and necrosis 1
- Pemetrexed: Antifolate agent that causes acute tubular injury and necrosis 1
- Methotrexate: Causes both crystalline nephropathy and acute tubular injury 1
Bisphosphonates
- Pamidronate: Associated with moderate FPPS inhibition, causing focal segmental glomerulosclerosis and acute tubular injury 1
- Zoledronic acid: More potent FPPS inhibitor that causes acute tubular injury and necrosis 1
Targeted Therapies
- BRAF inhibitors (vemurafenib and dabrafenib): Cause acute tubular injury through inhibition of mutated BRAF V600E kinase 1
- ALK inhibitors (crizotinib): Cause acute tubular injury through inhibition of mutated anaplastic lymphoma kinase 1
Other Medications
- Radiocontrast agents: Cause direct kidney tubule toxicity 1
- Amphotericin B: Direct tubular toxin 1
- Vancomycin: Can cause acute tubular injury, particularly at high doses 4
Mechanisms of Tubular Injury
Medications can cause direct tubular injury through several mechanisms:
Direct cellular toxicity: Drugs like aminoglycosides and cisplatin directly damage tubular cell mitochondria and other cellular components 4
Transport-mediated injury: Some drugs accumulate in tubular cells through specific transporters:
- Aminoglycosides enter via endocytosis at the apical membrane
- Cisplatin enters via organic cation transporters at the basolateral membrane
- Tenofovir enters via organic anion transporters 4
Intratubular crystal formation: Drugs like methotrexate can precipitate within tubular lumens 4
Prevention Strategies
To minimize the risk of medication-induced tubular injury:
- Use the shortest duration of therapy clinically appropriate
- Ensure adequate hydration during treatment
- Limit concurrent use of other nephrotoxic drugs
- Monitor drug levels closely (especially for aminoglycosides)
- Consider alternative less nephrotoxic medications when possible 5
- Monitor renal function, electrolytes, urine output, and urinalysis during therapy 3
Clinical Monitoring
For high-risk medications like aminoglycosides:
- Monitor serum drug concentrations to avoid toxic levels
- Check renal function before and during treatment
- Adjust dosing based on renal function
- Consider once-daily dosing regimens when appropriate 5
For patients receiving potentially nephrotoxic medications, early detection of tubular injury is crucial for preventing progression to more severe kidney damage and improving outcomes.